直接面向消费者的基因测试市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00018484
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 162
Buy Now

【研究报告】2022年直接面向消费者的基因检测市场规模为17.1584亿美元,预计到2030年将达到71.9168亿美元,预计2022年至2030年复合年增长率为19.6%。
市场洞察和分析师观点:
直接面向消费者的基因检测是医疗保健行业快速增长的部分。有吸引力的媒体和广告,例如互联网、印刷版面、广播和电视,广泛导致了直接面向消费者的遗传学的普及。此外,通过商店和电子商务平台轻松获得测试套件正在引领市场的增长。此外,许多消费者基因检测公司进入市场也促进了直接面向消费者的基因检测市场的增长。
人们对直接面向消费者的基因检测的认识不断增强,为直接面向消费者的基因检测市场规模的增长创造了机会。此外,为家庭护理环境提供基因检测的技术不断进步,增加了对非处方基因检测的需求。产品发布的增加刺激了对先进基因检测试剂盒的需求。例如,2023 年 7 月,Quest Diagnostics 推出了一项以消费者为中心的基因测试 Genetic Insights。该试剂盒将利用唾液检查 36 个基因,并帮助分析 24 种潜在的遗传状况。
增长动力和挑战:
遗传疾病的全球负担正在增加。根据《卫报》2022 年发表的一篇文章,全球约有 5% 的人口受到镰状细胞病的影响,全球每年约有 30 万婴儿出生时患有镰状细胞贫血症。世界卫生组织估计,每 1000 人中就有 10 人受到影响。这意味着全世界有 70 至 8000 万人患有其中一种疾病。 2020 年,在线人类孟德尔遗传 (OMIM) 资源列出了 6,594 种已知分子遗传缺陷的疾病,包括 4,225 个基因。根据 Orphanet 和 OMIM 数据库,这一数字持续增加,每年大约有 50-60 种新的遗传疾病。 NIH 未确诊疾病计划和网络以及国际罕见病研究联盟等举措进一步加快了新型遗传疾病的发现速度。
根据 CDC 的数据,每 500 名非裔美国人中就有 1 人被诊断患有镰状细胞病,并且每 12 个非洲裔美国人中就有 1 个携带常染色体隐性突变。据镰状细胞协会称,2021 年,英国有近 15,000 人患有镰状细胞病,每年有近 270 名婴儿出生时患有镰状细胞病。此外,印度等发展中国家受该病影响最严重。据 ETHealthWorld 报道,印度估计有 1800 万镰状细胞性状 (SCT) 患者,约 140 万患者患有镰状细胞病 (SCD)。囊性纤维化、镰状细胞性贫血、阿尔茨海默病 (AD) 和某些癌症等遗传性疾病的急剧增加预计将增加对 DTC 基因检测的需求。据阿尔茨海默病协会称,到 2023 年,近 670 万 65 岁的美国人将患有阿尔茨海默病相关的痴呆症。此外,到 2060 年,这一数字预计将增至 1,380 万,且尚无减缓或治愈该疾病的突破。
新生儿遗传性疾病的发病率也在增加。根据世界卫生组织2022年报告,神经管缺陷、唐氏综合症和心脏缺陷是几种常见的严重先天性残疾。据美国疾病预防控制中心 (CDC) 称,在美国,唐氏综合症每年影响近 6,000 名新生儿,即每 700 名婴儿中就有一名患有唐氏综合症;在印度,每年有近 23,000 至 29,000 名儿童(即 831 名儿童中就有一名)患有唐氏综合症。根据2021年《家庭医学和初级保健杂志》发表的题为“神经管缺陷:不同类型以及神经形成过程及其临床意义的简要概述”的报告,超过30万例神经管缺陷(NTD)病例每年在世界范围内都有记录。这些因素鼓励引入针对遗传性疾病的基因检测。
因此,全球遗传性疾病发病率的增加促进了直接面向消费者的基因检测市场的增长。
另一方面,高成本和隐私问题与直接面向消费者的基因测试相关可能会阻碍市场增长。许多制造商注重产品创新并集成下一代技术,引入高质量的DTC测试,导致产品价格上涨。例如,根据 MedlinePlus 的说法,根据测试的复杂性和疾病的严重程度,DTC 基因检测的费用从 100 美元到 3,000 美元不等。因此,由于负担能力问题,欠发达和发展中地区对遗传服务的需求可能会下降。
战略见解
报告细分和范围:
直接面向消费者的基因检测市场分为测试类型、技术、分销渠道。根据测试类型,市场分为血统测试、营养基因组学测试、预测测试、携带者测试等。根据技术,市场分为全基因组测序、单核苷酸多态性芯片、靶向分析等。从分销渠道来看,市场分为线上和线下。根据地理位置,市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、韩国、澳大利亚和亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
细分市场分析:
根据测试类型,血统测试细分市场在 2022 年占据最大的市场份额,而预测测试细分市场预计在 2022 年至 2030 年期间复合年增长率最高.
祖先测试,也称为谱系或基因谱系测试,是直接面向消费者 (DTC) 基因测试服务的重要组成部分。这些测试旨在让个人深入了解他们的遗传遗产、祖先起源以及与远亲的联系。祖先测试分析个体 DNA 的特定区域,以估计其祖先起源。这些区域被称为遗传标记,它们与来自世界各地不同人群的 DNA 样本数据库进行比较。血统测试通常提供种族或祖先起源估计,将一个人的遗传遗产分解为百分比或区域。例如,一项测试可能表明某人有 30% 的欧洲血统、40% 的非洲血统和 30% 的亚洲血统。一些血统测试可能会提供有关古代迁徙模式以及祖先在全球迁徙时可能采取的路线的信息。
一些公司提供专门的测试来追踪父系 (Y-DNA) 和母系 (线粒体或 mtDNA) 谱系。这些测试可以深入了解一个人的直接母系和父系血统。
高级血统测试可以深入了解深层血统,例如单倍群,这是数千年前具有共同祖先的人群所共享的古老遗传标记。许多 DTC 基因测试公司提供在线工具和平台,用于构建家谱、与亲戚联系以及探索家谱。
祖先测试通常用于娱乐和教育目的。这可能是一种令人兴奋的方式来了解一个人的遗产并与更广泛的谱系学家和 DNA 爱好者社区建立联系。
直接面向消费者的基因测试市场,按测试类型 - 2022 年和 2030 年
在技术方面,单核苷酸多态性芯片细分市场在 2022 年占据最大的市场份额,预计 2022-2030 年复合年增长率最高。
从分销渠道来看,在线细分市场在 2022 年占据更大的市场份额,预计2022-2030 年市场复合年增长率高达 19.8%。
区域分析:
根据地理位置,直接面向消费者的基因检测市场分为北美、欧洲、亚太地区、中东地区东部和非洲,以及南美洲和中美洲。由于遗传疾病的日益流行、研发支出的高额、美国食品和药物管理局 (FDA) 的产品批准以及技术的进步,北美占据了重要的市场份额。在预测期内,大型医疗保健企业的存在以及直接面向消费者的基因检测的日益使用将继续为该地区的市场增长提供机会。此外,各国政府为解决人们对遗传疾病日益增长的担忧而提供的支持不断增加,有利于北美直接面向消费者的基因检测市场的进步。美国在北美直接面向消费者的基因检测市场中占有最大的市场份额。 FDA 于 2022 年批准了 23andMe 的 DTC 基因测试,用于遗传性前列腺癌标记物。直接面向消费者的基因检测在美国越来越受欢迎。据美国国立卫生研究院 (NIH) 称,DTC 基因检测通过电视、平面广告或互联网直接向消费者推销。因此,遗传性疾病的患病率不断上升,加上越来越多地采用先进的基因疗法来治疗慢性疾病,推动了美国市场的发展。
此外,预计亚太地区在预测期内将出现最快的增长速度。亚太地区直接面向消费者的基因检测市场的激增归因于对优质治疗解决方案的需求不断增加、对遗传性疾病早期筛查意识的提高以及对研发活动的日益关注。此外,基因组学研发的激增、大量患者以及医疗保健基础设施的升级预计将有利于预测期内亚太地区直接面向消费者的基因检测市场的增长。
行业发展和未来机遇:
市场上主要直接面向消费者的基因检测公司的各种举措如下:
2023 年 9 月,23andMe Holding Co. 和 Sickle Cell 101 联手提高人们对镰状细胞病的认识承运人状态。此次合作将包括 DNA 测试以及为最多 1,000 名合格参与者提供 23andMe 的健康 + 祖先服务,23andMe 将为 Sickle Cell 101 提供资金支持以支持这一努力。 2022 年 11 月,Myriad Genetics, Inc. 收购了 Gateway Genomics, LLC 是一家个人基因组公司和消费者基因测试开发商,其中包括销量第一的 SneakPeek 早期性别 DNA 测试。 SneakPeek 在怀孕六周时揭示婴儿的性别,这是唯一可用于最早方法的家庭测试。2020 年 8 月,Ancestry 推出了由下一代测序技术支持的 Ancestry Health,这有助于了解消费者在获取婴儿性别方面的重要进展。健康。 Ancestry Health 背后的先进检测技术通过基因筛查提供了一套完整且扩展的健康状况,例如心脏病、乳腺癌、结肠癌和血液疾病。竞争格局和主要公司:
一些著名的 DTC 基因市场上运营的测试公司有 Genesis Healthcare Co;祖先基因组公司;色彩健康公司;螺旋公司;无数遗传学公司;生活DNA有限公司; 23andMe 公司;遗传技术有限公司; Gene By Gene Ltd 和 Full Genomes Corp Inc. 这些公司专注于有机和无机战略,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们的全球业务使他们能够为大量客户提供服务,从而扩大他们的市场份额。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is direct-to-consumer genetic testing?

direct-to-consumer genetic testing is also known as direct-access genetic testing, at-home genetic testing, DTC genetic testing, home DNA testing, and Ancestry testing, also known as genealogy testing. DTC genetic testing differs from conventional and is performed in a homecare setting. Thus, the genetic test kits are sold as OTC products and can be purchased online. During the process of direct-to-consumer genetic testing, it allows people to access their genetic information by avoiding a healthcare provider or health insurance company.

What are the driving factors for the direct-to-consumer genetic testing market?

The market's growth is attributed to the growing incidence of genetic disorders, and increasing awareness about the potential benefits of genetic testing drives the market. On the other hand, the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.

Who are the major players in the direct-to-consumer genetic testing market?

The direct-to-consumer genetic testing market majorly consists of players such as Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 7andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.

What is the segmentation of the direct-to-consumer genetic testing market?

The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030. The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.

Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and was anticipated to register the highest CAGR during 2022–2030.

The List of Companies - Direct-to-Consumer Genetic Testing Market

  1. Genesis Healthcare Co
  2. Ancestry Genomics Inc.
  3. Color Health Inc.
  4. Helix Inc.
  5. Myriad Genetics, Inc.
  6. Living DNA Ltd
  7. 7andMe Inc.
  8. Genetic Technologies Ltd
  9. Gene By Gene Ltd
  10. Full Genomes Corp Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports